Bayer reaches Roundup settlement that could cost the company billions

The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma – a blood cancer linked to the herbicide.
This is a brief. The reporting belongs to NPR Health — read the complete story, with full context and credits, at the source.
Read the full story at NPR Health ↗npr.org
More from the Health desk

Cancer is no longer America’s biggest fear

Overton’s nomination withdrawal means no clear end for FDA leadership vacuum

Virginia child dies in state’s first measles-associated death of 2026
Princess Catherine reflects on cancer journey in new documentary
